HealthQuill Schizophrenia diagnosis
US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.
Drugs Health Pharma

Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms

US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.

Read More
The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable treatments for its 84 million patients in the bloc.
Drugs Health Pharma

KarXT by Karuna Therapeutics offers hope for improved schizophrenia management

HQ Team, December 18, 2023: For individuals grappling with schizophrenia, the road to treatment is often marked by a lifelong commitment to antipsychotic.

Read More
At least 30% of cases of schizophrenia in young adults could have been staved off in Denmark by preventing cannabis use disorder, a study of more the six million people revealed.
Drugs Health Medical Pharma

Cannabis disorder prevention can obviate 30% schizophrenia cases in Denmark: Study 

HQ Team May 8, 2023: At least 30% of cases of schizophrenia in young adults could have been staved off in Denmark by.

Read More
X